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Wnt-4, a member of the Wnt family of locally acting secreted growth factors, is the first signaling molecule shown
to influence the sex-determination cascade. In mice, a targeted deletion of Wnt-4 causes the masculinization of XX
pups. Therefore, WNT-4, the human homologue of murine Wnt-4, is a strong candidate gene for sex-reversal
phenotypes in humans. In this article, we show that, in testicular Sertoli and Leydig cells,Wnt-4 up-regulatesDax1,
a gene known to antagonize the testis-determining factor, Sry. Furthermore, we elucidate a possible mechanism for
human XY sex reversal associated with a 1p31-p35 duplication including WNT-4. Overexpression ofWNT-4 leads
to up-regulation of DAX1, which results in an XY female phenotype. Thus, WNT-4, a novel sex-determining gene,
and DAX1 play a concerted role in both the control of female development and the prevention of testes formation.
These observations suggest that mammalian sex determination is sensitive to dosage, at multiple steps in its pathway.
Introduction
To date, Wnt-4 is the only signaling molecule known to
be involved in sex determination. Wnt-4 is a member of
the Wnt family of secreted signals, which act locally, via
Frizzled receptors and a cascade of intracellular signals
leading to the transcriptional activation of a host of
genes (Dale 1998). Wnt-4 expression is down-regulated
in the developing male gonad after E11.5, although it
persists in the developing ovary (Vainio et al. 1999). In
addition, targeted deletion of Wnt-4 results in the mas-
culinization of XX mice, with rudimentary development
of the masculine internal (Wolffian) ducts and with de-
generation of the female (Mu¨llerian) reproductive tract
(Vainio et al. 1999). These observations suggest that
Wnt-4 plays an important role in the developing ovary.
In humans, sex is determined by a regulatory cascade
of sex-linked and autosomal genes (Vilain and McCabe
1998; Koopman 1999; Swain and Lovell-Badge 1999).
Most encode transcription factors such as SRY, SOX9,
DAX1, and SF1, which are expressed, in a sexually
dimorphic fashion, during gonadal development. The
timing and dosage of the expression of these genes
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(along with many others yet to be identified) directs the
bipotential urogenital ridge to develop either as testes,
in males, or as ovaries, in females, but the particulars
of this regulatory cascade remain unclear. Mutations in
either of the high-mobility group (HMG)–box tran-
scription factors, SRY (SRY [MIM 480000]) and SOX9
(SOX9 [MIM 114290]), cause the feminization of XY
fetal gonads, leading to XY sex reversal with gonadal
dysgenesis (Koopman 1999). DAX1, a member of the
nuclear hormone-receptor superfamily (Zanaria et al.
1994), maps to the dosage-sensitive sex reversal (DSS)
locus on Xp21.3. In humans, duplications of DSS (DSS
[MIM 300018]) have been shown to cause XY sex re-
versal (Bardoni et al. 1994; Swain et al. 1996). SF1,
another nuclear hormone receptor, has been shown to
regulate Dax1 expression (Vilain et al. 1997), and mu-
tation of SF1 (SF1 [MIM 184757]) has been associated
with XY sex reversal and with adrenal insufficiency
(Achermann et al. 1999).
In mice, Dax1 exhibits an expression pattern similar
to that ofWnt-4—that is, down-regulated in males after
the beginning of testis differentiation (at E12.5) but per-
sistent in the ovary throughout fetal development
(Swain et al. 1996). Overexpression of DAX1 in mice
leads to XY sex reversal, suggesting that it antagonizes
SRY (Swain et al. 1998). DAX1 may therefore contrib-
ute to ovarian development, as well as prevent testicular
formation (Goodfellow and Camerino 1999). This
study provides evidence that, by up-regulating DAX1
expression, WNT-4 may act in concert with DAX1, to
accomplish these developmental goals.
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Material and Methods
Gene Structure and Localization
The chromosomal localization of WNT-4 was deter-
mined by use of primers flanking exon 2 (forward
primer, 5′-ATCCAGAGAGAAGTCGGCAGCC-3′; re-
verse primer, 5′-CCCGTTGCTCACGAGCGTCTC-3′)
and of the GeneBridge 4 radiation-hybrid panel (Re-
search Genetics) as a template for PCR. The radiation-
hybrid localization was confirmed by FISH using a bac-
terial artificial chromosome (BAC) probe containing
WNT-4 obtained by PCR screening of a human BAC
library (Genome Systems), by use of the primers listed
above. The sequence of exon 1 was verified by 5′ RACE-
PCR version 2.0 (Gibco), on RNA from MDA-415 cells
(American Type Culture Collection), a humanmammary
cell line, by use of a primer in exon 3 (5′-CCGAAGAGA-
TGGCGTACACGAAGG-3′), for the reverse transcrip-
tion, and by use of two primers in exon 2 (5′-ACCTTGC-
CGAAGACGGGCAAGG-3′ and 5′-CCAGCGCCGG-
TTCCGGAACTGG-3′), for nested PCR. An annealing
temperature of 55C was used for the 35 cycles in each
nested PCR.
Molecular Cytogenetic Analysis
We identified an XY female patient carrying a du-
plication of 1p31-p35. This patient’s duplication was
characterized by use of BAC probes mapping to sever-
al cytogenetic bands between 1p31 (BAC 395G6) and
the 1p terminus (BAC 397E07) and by use of a pool
of 3–4-kb genomic probes specific to various exons of
WNT-4. Whole chromosome 1–specific paint probes
(Coatasome 1 Total Chromosome Probe; Oncor) were
used for painting.
Expression of WNT-4 in Fibroblasts
Total RNA was extracted, by use of Trizol reagent
(Gibco), from cultures of skin fibroblasts isolated from
the patient and from normal human foreskin (American
Type Culture Collection). One microgram of total RNA
was used as the template for reverse transcriptase–PCR
(RT-PCR), to amplify a 360-bp fragment ofWNT-4 con-
taining exons 2–5 (forward primer, 5′-GCTGGAA-
CTGCTCCACACTCG-3′; reverse primer, 5′-CCCGC-
ATGTGTGTCAGGATGG-3′) and a 587-bp fragment of
b-actin, by use of primers purchased from Clontech. The
reverse transcription was performed at 42C for 1 h,
followed by a PCR protocol including 35 cycles at an
annealing temperature of 58C.
Transfections
MLTC-1 and TM4 cell lines (American Type Culture
Collection) were transfected by LipofectAmine (Gibco),
with Wnt-4 (a gift from Dr. A. McMahon), SF-1 (Vilain
et al. 1997), and pcDNA3.1 (Invitrogen), the expression
vector in which Wnt-4 and SF1 are cloned. In each ex-
periment, 106 cells were transfected with 4 mg of each
of the specified plasmids. A vector expressing Renilla
luciferase (Promega) was used as a control with regard
to transfection efficiency. Total RNA was extracted from
these transfections after 24–36 h, as described above,
and was examined by either RT-PCR or northern anal-
ysis. RT-PCR was performed with primers to amplify a
585-bp fragment of Dax1, which spans the intron/exon
splice site (Tamai et al. 1996), with b-actin used as a
control. The reverse transcription was performed on 1
mg of total RNA from each sample, at 42C for 1 h,
followed by a PCR protocol including 25 cycles at an
annealing temperature of 57C. Ten micrograms of total
RNA were used in each lane, for the northern analysis,
and full-length Dax1 and b-actin cDNAs were used as
probes.
Results
To assess the role that WNT-4 (WNT-4 [MIM 603490])
plays in human sex determination, we cloned the human
homologue of murine Wnt-4, by searching the GenBank
database for human BAC sequences with high homology
to murine Wnt-4. This search was assisted by the se-
quencing of the human genome, which allowed the iden-
tification of a human BAC clone containing most of the
genomic sequence of WNT-4, lacking only exon 1 and
the 5′ end of intron 1. In addition, this BAC clone dem-
onstrated the physical proximity ofWNT-4 to theCDC42
gene, which is located ∼25 kb downstream. Using 5′
RACE-PCR on RNA from human mammary cells, we
amplified and sequenced exon 1 ofWNT-4.We confirmed
all coding regions of exons 2–5 by PCR amplification and
sequencing of normal humanDNA. After determining the
length of intron 1 by PCR amplification between exon 1
and the 3′ end of intron 1 (data not shown), we completed
the map of the genomic structure of WNT-4 (fig. 1a).
Alignment of the predicted mouse and human proteins
revealed high evolutionary conservation, with 98.9% se-
quence identity and 99.7% sequence similarity. In fact,
these homologues differ at only four amino acid residues,
clustered near the C-terminus (fig. 1b). By radiation-hy-
brid mapping, we localized WNT-4 to the distal end of
chromosome 1p, betweenmarkersWI-3177 andWI-5581
(data not shown). To confirm these data, we identified a
BAC clone containing the full sequence of WNT-4, by
PCR screening of a human BAC library, by using the
primers listed above. Using this BAC as a probe, we lo-
calized WNT-4 to cytogenetic band 1p35, by FISH (fig.
1c and d). This cytogenetic localization is in good agree-
ment with the results of the radiation-hybrid mapping.
According to the Human-Mouse Homology Map of the
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Figure 1 Genomic structure and localization of WNT-4. a, Genomic structure of WNT-4. The lengths of the exons appear above
corresponding boxes, and the lengths of the introns appear below. b, Alignment of human and mouse Wnt-4 predicted protein sequences. The
differences are denoted by white letters. c, FISH with a BAC probe containing WNT-4, on a normal metaphase spread. For easier comparison
with the chromosome 1 ideogram, only chromosome 1 is shown. d, Ideogram of chromosome 1, illustrating normal GPG-banding. The guideline
indicates the locus that corresponds to the WNT-4 FISH signal on chromosome 1.
National Center for Biotechnology Information, this re-
gion of human chromosome 1p is highly syntenic to
mouse chromosome 4q, where the murine homologue of
CDC42 is located between markers D4Mit31 and
D4Mit13. These data, in combination with the physical
proximity of the CDC42 and WNT-4 loci in the human
genome, suggest that murine Wnt-4 also maps to mouse
chromosome 4q.
Four XY patients with a duplication of part of chro-
mosome 1p have been described as having sexual phe-
notypes ranging from cryptorchidism (Cousineau et al.
1981; Mohammed et al. 1989) to sex reversal (Elejalde
et al. 1984; Wieacker et al. 1996). We obtained fibro-
blasts from one such XY sex-reversed patient carrying
a cytogenetic duplication of 1p31-p35, who presented
with ambiguous external genitalia accompanied by se-
vere hypospadias, fibrous gonads with rudimentary tu-
bules, and remnants of both Mu¨llerian and Wolffian
structures (Elejalde et al. 1984). In addition, the pres-
ence of a rudimentary uterus and vagina in this patient
suggests that secretion ofMu¨llerian inhibiting substance
(MIS) was absent from the gonads during embryogen-
esis. Since MIS secretion is an early indication of testes
differentiation, it is likely that testes never developed in
this XY individual. The cause of this sex reversal is likely
to be a gene within the duplication that this patient
carries.
To better characterize the duplication found in this
patient, we performed FISH with BAC probes known
to map to cytogenetic bands 1p31 and 1pter (Korenberg
et al. 1999), as well as with a pool of probes specific
to WNT-4. Using whole chromosome 1 paint probes,
we verified that this cytogenetic abnormality was a clas-
sic duplication and not a translocation (fig. 2a). We
confirmed that the duplicated region includes 1p31 (fig.
2b) and extends to a distal breakpoint beyond theWNT-
4 locus at 1p35 (fig. 2c). Figure 2c demonstrates that
the WNT-4 locus is duplicated in this patient. We also
found that the terminal band of 1p is not involved in
the duplication (fig. 2d). To study the effects that this
Jordan et al.: WNT-4 and Dosage-Sensitive Sex Reversal 1105
Figure 2 FISH mapping of the patient’s duplication. Larger, filled white arrows indicate the chromosome 1 carrying the duplication;
smaller arrows indicate the normal chromosome 1. a, Metaphase spread hybridized with whole chromosome 1–specific paint (Coatasome 1
Total Chromosome Probe; Oncor). b, Metaphase spread and interphase nucleus hybridized with probes specific to cytogenetic band 1p31 (BAC
395G6). c, Metaphase spread hybridized with nonoverlapping 3–4-kb probes specific to genomic sequences of WNT-4. d, Metaphase spread
hybridized with probes specific to the 1p terminus (BAC 397E07).
duplication has on WNT-4 expression, RT-PCR studies
were performed. WNT-4 was expressed in the fibro-
blasts of this XY sex-reversed patient, but it was not
expressed in normal male fibroblasts (fig. 3). Although
this WNT-4 expression in the patient’s fibroblasts
would probably not be physiologically relevant to the
sex reversal, it does demonstrate thatWNT-4 expression
was misregulated in at least one tissue type, and it also
raises the possibility that WNT-4 may have been mis-
regulated in the developing gonads, where its expression
could have altered the gonadal phenotype. However,
since tissue from the developing gonad of this patient
was not available for study, we cannot formally con-
clude that WNT-4 was misexpressed in this tissue.
Because of the phenotypic similarities between this pa-
tient with an additional dose ofWNT-4 and patientswith
an additional dose ofDAX1, we hypothesized that these
two genes may act in series in the sex-determination cas-
cade. To evaluate the effect of Wnt-4 overexpression on
Dax1 gene expression in vitro, full-length Wnt-4 cDNA
was transfected into cultured mouse Leydig cells (MLTC-
1), in which steroidogenesis takes place, and into Sertoli
cells (TM4), the supporting cell lineage of the testis. Be-
cause of its previously described role in the up-regulation
of Dax1 (Vilain et al. 1997; Kawabe et al.1999), SF1
was included in these transfection experiments, as a pos-
itive control. In both Leydig and Sertoli cells, transfection
of Wnt-4 and cotransfection of Wnt-4 and SF1 resulted
in a strong up-regulation of endogenousDax1 (fig. 4a–c).
Discussion
In this study, we have cloned human WNT-4 and have
localized it to 1p35. Furthermore, we have identified an
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Figure 3 Comparison of expression of WNT-4 in RNA from patient fibroblasts and from control fibroblasts. Lanes denoted “RT”
contain RT; lanes denoted “RT” lack RT. Arrows indicate the 587-bp b-actin RT-PCR product and the 360-bp WNT-4 RT-PCR product.
XY sex-reversed patient carrying a duplication ofWNT-
4 in whom WNT-4 is overexpressed. In addition, we
have proposed that WNT-4 plays a role in the sex-de-
termination cascade, by demonstrating that Dax1 ex-
pression is up-regulated by Wnt-4.
Wnt molecules trigger a cascade of intracellular sig-
nals resulting in transcriptional activation of a variety
of target genes. In vertebrates, two pathways for Wnt
signaling have been identified. In one Wnt pathway, the
transcriptional activation is thought to occur as a result
of G-protein–mediated modulation of internal calcium
concentrations (Ku¨hl et al. 2000). In the canonical Wnt
pathway, the activation is accomplished through an in-
teraction between b-catenin and TCF (Dale 1998). This
transcriptionally active complex binds to a TCF-re-
sponse element and activates the transcription of target
genes. Several sequences closely related to the TCF-re-
sponse element can be found within the promoter of
Dax1, at nucleotide positions 150, 2200, 3300,
and 4000 in the mouse (data not shown). Although
these TCF sites could mediate a direct control of Dax1
by the Wnt-4 signaling pathway, further study of this
interaction will be necessary to determinewhetherDax1
is a direct or an indirect target of Wnt-4 signaling.
Control of Dax1 expression by Wnt-4 should result
in the reduction ofDax1 expression inWnt-4–knockout
mice. Although this was not reported in the original
description (Vainio et al. 1999), subsequent in situ hy-
bridization with Dax1 in these Wnt-4–knockout mice
revealed a lower level of Dax1 expression in the gonads
than in normal controls (A. Swain, unpublished obser-
vation). We observed control of Dax1 expression by
Wnt-4 signaling in both Leydig and Sertoli cell lines,
suggesting a concerted role for these two genes in ste-
roidogenesis as well as in the initial steps of sex deter-
mination. Both Wnt-4 and Dax1 are turned off in the
developing testis (at E11.5 and E12.5, respectively) and
remain expressed in the developing ovary (Swain et al.
1996; Vainio et al. 1999), and both genes, in excess,
can feminize XY embryos (Bardoni et al. 1994; Swain
et al. 1998). These findings suggest thatDax1 andWnt-
4 play a common role in the prevention of testis for-
mation. However, although chromosomal duplications
involving either WNT-4 or DAX1 result in XY sex re-
versal, targeted deletions of these genes in mice give rise
to different phenotypes. Absence ofWnt-4 results in the
masculinization of XX pups, including the presence of
Leydig cell markers (Vainio et al. 1999). On the other
hand, absence of Dax1 from XX pups has no effect on
sexual development (Yu et al. 1998). The more severe
phenotype observed in the Wnt-4–knockout mice is
consistent with our finding that Wnt-4 acts upstream
from Dax1. Also, it suggests that Wnt-4 plays addi-
tional roles in female development, such as in the sup-
pression of Leydig cell formation. Alternatively, the
Dax1-knockout phenotype may be the result of a hy-
pomorphic allele, since the adrenal hypoplasia that is
caused by DAX1 mutations in humans was not ob-
served in this model either (Yu et al. 1998). It is also
possible that WNT-4 may act independently of DAX1
to cause sex reversal. A WNT-4-transgenic-mouse
model would be necessary for elucidation of the inter-
action between WNT-4 and DAX1 and to test directly
the hypothesis that WNT-4 causes sex reversal via its
control of DAX1 expression.
Transgenic experiments have shown that, in XYmice,
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Figure 4 Regulation of Dax1 by Wnt-4 and SF1. In a, the upper panel shows expression of Dax1 in Sertoli (TM4) cells, by RT-PCR
after transfection with Wnt-4 (lanes 1–3), Wnt-4 and SF1 (lanes 4–6), SF1 (lanes 7–9), and Renilla luciferase control vector (lane 10), and the
lower panel shows expression of b-actin from the same samples. In b, the upper panel shows expression of Dax1 in Leydig (MLTC-1) cells,
by RT-PCR after transfection with Wnt-4 (lanes 1 and 2), Wnt-4 and SF1 (lanes 3 and 4), and Renilla luciferase control vector (lane 5), and
the lower panel shows expression of b-actin from the same samples. The templates for positive and negative controls are mouse ovarian RNA
and water, respectively. In c, the upper panel shows expression of Dax1 in Sertoli (TM4) cells, by northern blot after transfection with Wnt-4
(lanes 1–3), Wnt-4 and SF1 (lanes 4–6), SF1 (lanes 7–9), and pcDNA3.1 (lanes 10–12), as well as RNA from a mock-transfected control (lane
13), and the lower panel shows expression of b-actin on the same blot.
Sry action is antagonized by Dax1 (Swain et al. 1998).
Wnt-4 could be the molecular signal linking these two
transcription factors. Sry may antagonize Dax1 via
Wnt-4, preventing its “antitestis” role, which, in turn,
would result in male development. In addition, we hy-
pothesize that Sry could antagonize Wnt-4 either by
direct transcriptional regulation ofWnt-4 expression or
by interfering with the Wnt signaling cascade. The for-
mer mechanism is consistent with the serial expression
pattern of Sry (peak at 11.5 dpc) (Koopman et al. 1990;
Hacker et al. 1995), Wnt-4 (down-regulated in males,
at 11.5 dpc) (Vainio et al. 1999), and Dax1 (down-
regulated in males, at 12.5 dpc) (Swain et al. 1996,
1998). The latter mechanism is consistent with recent
experimental evidence of direct inhibition of Wnt sig-
naling molecules by Xenopus Sox3 (Zorn et al. 1999),
the closest homologue to Sry (Graves 1998).
We have localized WNT-4 to cytogenetic band 1p35,
a segment syntenic to the distal end of mouse chro-
mosome 4q. Interestingly, this region of mouse chro-
mosome 4q has already been implicated in XY sex re-
versal in mice, since it is thought to contain tda-1, an
autosomal locus involved in the XY sex-reversal phe-
notype observed in C57BL/6J mice (musculus strain)
carrying a Y chromosome of Poschiavinus (domesticus
strain) origin (Eicher et al. 1996). Linkage analysis of
the XY sex-reversed mice from this congenic strain re-
vealed that a gene at this tda-1 locus prevented normal
male development and may also have served to promote
ovarian development (Eicher et al. 1996). Several mark-
ers on mouse chromosome 4q (from D4Mit31 to Tel4q)
exhibited significant evidence for linkage with the tda-
1 locus, with peak x2 values near D4Smh6b. Although
theWnt-4 locus is not located at the absolute peak, our
investigation suggests that it maps within this range of
significant x2 values. Therefore, because of its chro-
mosomal localization and its proposed function as a
pro-ovary gene, Wnt-4 is a strong candidate for tda-1
in this mouse model.
In this study, we have identified an XY female patient
in whomWNT-4 is overexpressed, suggesting thatWNT-
4 is a sex-determining gene in humans. In normal testic-
ular cells, Wnt-4 up-regulates the expression of Dax1,
and it is therefore likely that overexpression of WNT-4
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in an XY female results in an up-regulation of DAX1 in
the testicular tissue. Furthermore, Wnt-4 up-regulation
mimics the phenotype observed in XY females with du-
plication of DSS, a 160-kb locus on Xp21.3 containing
DAX1 (Bardoni et al. 1994). These findings lead us to
conclude that XY sex reversal associated with overex-
pression of WNT-4 is a new example of sex reversal
associated with the dosage sensitivity of a sex-determin-
ing gene. BothDAX1 duplication observed inXY females
(Bardoni et al. 1994) and SOX9 duplication described
in an XX male (Huang et al. 1999) suggest that gene
dosage is critical at most steps of the sex-determining
pathway. However, the relatively low frequency (1/
20,000) reported for sex reversal in humans (McElreavey
et al. 1995) indicates that gene dosage may be tightly
controlled in human sex determination.
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